Anebulo Pharmaceuticals, Inc. (ANEB)
0.28
0.00 (0.00%)
USD |
OTCM |
Nov 18, 16:00
Anebulo Pharmaceuticals Shareholders Equity (Quarterly) : 7.936M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 7.936M |
| September 30, 2025 | 9.737M |
| June 30, 2025 | 11.66M |
| March 31, 2025 | 13.46M |
| December 31, 2024 | 14.96M |
| September 30, 2024 | 1.899M |
| June 30, 2024 | 3.812M |
| March 31, 2024 | 4.985M |
| December 31, 2023 | 6.487M |
| September 30, 2023 | 8.331M |
| June 30, 2023 | 10.60M |
| March 31, 2023 | 12.94M |
| Date | Value |
|---|---|
| December 31, 2022 | 15.52M |
| September 30, 2022 | 19.12M |
| June 30, 2022 | 15.07M |
| March 31, 2022 | 17.16M |
| December 31, 2021 | 18.91M |
| September 30, 2021 | 19.89M |
| June 30, 2021 | 21.41M |
| March 31, 2021 | -6.460M |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | 2.805M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 637.11M |
| Corcept Therapeutics, Inc. | 833.74M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 81.53B |
| Eli Lilly & Co. | 40.27B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.422M |
| Total Liabilities (Quarterly) | 1.486M |